Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan;77(1):13-9.
doi: 10.1016/j.jbspin.2009.05.011. Epub 2009 Dec 21.

New insights in synovial angiogenesis

Zoltán Szekanecz  1 , Timea Besenyei, György Paragh, Alisa E Koch
Affiliations
Review

New insights in synovial angiogenesis

Zoltán Szekanecz et al. Joint Bone Spine. 2010 Jan.

Abstract

Angiogenesis is the formation of new capillaries from pre-existing vessels. A number of soluble and cell-bound factors may stimulate neovascularization. The perpetuation of angiogenesis involving numerous soluble and cell surface-bound mediators has been associated with rheumatoid arthritis (RA). These angiogenic mediators, among others, include growth factors, primarily vascular endothelial growth factor (VEGF) and hypoxia-inducible factors (HIFs), as well as pro-inflammatory cytokines, various chemokines, cell adhesion molecules, proteases and others. Among the several potential angiogenesis inhibitors, targeting of VEGF, HIF-1, angiopoietin and the alpha(V)beta(3) integrin, as well as some endogenous or synthetic compounds including angiostatin, endostatin, paclitaxel, fumagillin analogues, 2-methoxyestradiol and thalidomide seems to be promising for the management of synovial inflammation and angiogenesis. A complete review of antiangiogenic drugs used in animal models of arthritis or human RA is available in a table.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors have no conflicts of interest to declare.

Figures

Fig 1
Fig 1
The process of angiogenesis. Both soluble and cell surface-bound angiogenic factors trigger endothelial activation, sprouting, lumen formation and then the formation of new vessels.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: ‘vascular rheumatology’. Arthritis Res Ther. 2008;10:224. - PMC - PubMed
    1. Szekanecz Z, Koch AE. Mechanism of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3:635–643. - PubMed
    1. Lainer-Carr D, Brahn E. Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol. 2007;3:434–442. - PubMed
    1. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442–447. - PubMed
    1. Szekanecz Z, Koch AE. Chemokines and angiogenesis. Curr Opin Rheumatol. 2001;13:202–208. - PubMed

Publication types

MeSH terms

Substances